相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Expanding roles for CD4T cells and their subpopulations in tumor immunity and therapy
Mark J. Dobrzanski
FRONTIERS IN ONCOLOGY (2013)
Cytotoxic Chemotherapy and CD4+Effector T Cells: An Emerging Alliance for Durable Antitumor Effects
Zhi-Chun Ding et al.
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2012)
Analysis of Spontaneous Tumor-Specific CD4 T-cell Immunity in Lung Cancer Using Promiscuous HLA-DR Telomerase-Derived Epitopes: Potential Synergistic Effect with Chemotherapy Response
Yann Godet et al.
CLINICAL CANCER RESEARCH (2012)
T Cell Assays and MIATA: The Essential Minimum for Maximum Impact
C. M. Britten et al.
IMMUNITY (2012)
Promiscuous survivin peptide induces robust CD4+T-cell responses in the majority of vaccinated cancer patients
Melanie Widenmeyer et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Identification of HLA-A24-Restricted Novel T Cell Epitope Peptides Derived from P-Cadherin and Kinesin Family Member 20A
Ryuji Osawa et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2012)
Functional T Cells Targeting NY-ESO-1 or Melan-A Are Predictive for Survival of Patients With Distant Melanoma Metastasis
Benjamin Weide et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
HLA Anchor Optimization of the Melan-A-HLA-A2 Epitope within a Long Peptide Is Required for Efficient Cross-Priming of Human Tumor-Reactive T Cells
Joe-Marc Chauvin et al.
JOURNAL OF IMMUNOLOGY (2012)
West Nile Virus T-Cell Ligand Sequences Shared with Other Flaviviruses: a Multitude of Variant Sequences as Potential Altered Peptide Ligands
Keun-Ok Jung et al.
JOURNAL OF VIROLOGY (2012)
Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival
Steffen Walter et al.
NATURE MEDICINE (2012)
Identification of HLA-A2-restricted CTL epitopes of a novel tumour-associated antigen, KIF20A, overexpressed in pancreatic cancer
K. Imai et al.
BRITISH JOURNAL OF CANCER (2011)
Antigen Spreading Contributes to MAGE Vaccination-Induced Regression of Melanoma Metastases
Veronique Corbiere et al.
CANCER RESEARCH (2011)
Peptides derived from human insulin-like growth factor-II mRNA binding protein 3 can induce human leukocyte antigen-A2-restricted cytotoxic T lymphocytes reactive to cancer cells
Yusuke Tomita et al.
CANCER SCIENCE (2011)
A novel tumor-associated antigen, cell division cycle 45-like can induce cytotoxic T-lymphocytes reactive to tumor cells
Yusuke Tomita et al.
CANCER SCIENCE (2011)
Telomerase Peptide Vaccination Combined with Temozolomide: A Clinical Trial in Stage IV Melanoma Patients
Jon Amund Kyte et al.
CLINICAL CANCER RESEARCH (2011)
Telomerase Peptide Vaccination in NSCLC: A Phase II Trial in Stage III Patients Vaccinated after Chemoradiotherapy and an 8-Year Update on a Phase I/II Trial
Paal Fr. Brunsvig et al.
CLINICAL CANCER RESEARCH (2011)
Cancer immunotherapy - revisited
W. Joost Lesterhuis et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
Peptide binding predictions for HLA DR, DP and DQ molecules
Peng Wang et al.
BMC BIOINFORMATICS (2010)
CD4+ T-Cell Help in the Tumor Milieu Is Required for Recruitment and Cytolytic Function of CD8+ T Lymphocytes
Rinke Bos et al.
CANCER RESEARCH (2010)
Role of CD4+ Cytotoxic T Lymphocytes in the Control of Viral Diseases and Cancer
Debora Martorelli et al.
INTERNATIONAL REVIEWS OF IMMUNOLOGY (2010)
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer.
Philip W. Kantoff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Tumor Antigen-Specific FOXP3+ CD4 T Cells Identified in Human Metastatic Melanoma: Peptide Vaccination Results in Selective Expansion of Th1-like Counterparts
Camilla Jandus et al.
CANCER RESEARCH (2009)
The CD4+ T-Cell Response of Melanoma Patients to a MAGE-A3 Peptide Vaccine Involves Potential Regulatory T Cells
Violaine Francois et al.
CANCER RESEARCH (2009)
Simultaneous Infiltration of Polyfunctional Effector and Suppressor T Cells into Renal Cell Carcinomas
Sebastian Attig et al.
CANCER RESEARCH (2009)
An in vivo model of priming of antigen-specific human CTL by Mo-DC in NOD/Shi-scid IL2rγnull (NOG) mice
Mitsuhiro Inoue et al.
IMMUNOLOGY LETTERS (2009)
Concurrent Trastuzumab and HER2/neu-Specific Vaccination in Patients With Metastatic Breast Cancer
Mary L. Disis et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Vaccination against HPV-16 Oncoproteins for Vulvar Intraepithelial Neoplasia.
Gemma G. Kenter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Immunodominant HIV-1 Cd4+T Cell Epitopes in Chronic Untreated Clade C HIV-1 Infection
Danni Ramduth et al.
PLOS ONE (2009)
Identification of a Novel Tumor-Associated Antigen, Cadherin 3/P-Cadherin, as a Possible Target for Immunotherapy of Pancreatic, Gastric, and Colorectal Cancers
Katsunori Imai et al.
CLINICAL CANCER RESEARCH (2008)
Superior induction of anti-tumor CTL immunity by extended peptide vaccines involves prolonged, DC-focused antigen presentation
Martijn S. Bijker et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2008)
HLA-A2-restricted CTL epitopes of a novel lung cancer-associated cancer testis antigen, cell division cycle associated 1, can induce tumor-reactive CTL
Michiko Harao et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Treatment of metastatic melanoma with autologous CD4+T cells against NY-ESO-1
Naomi N. Hunder et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
A systematic assessment of MHC class II peptide binding predictions and evaluation of a consensus approach
Peng Wang et al.
PLOS COMPUTATIONAL BIOLOGY (2008)
Immunotherapy of established (pre) malignant disease by synthetic long peptide vaccines
Cornelis J. M. Melief et al.
NATURE REVIEWS CANCER (2008)
Identification of human leukocyte antigen-A24-restricted epitope peptides derived from gene products upregulated in lung and esophageal cancers as novel targets for immunotherapy
Takako Suda et al.
CANCER SCIENCE (2007)
Identification and characterization of a WT1 (Wilms tumor gene) protein-derived HLA-DRB1*0405-restricted 16-mer helper peptide that promotes the induction and activation of WT1-specific cytotoxic T lymphocytes
Fumihiro Fujiki et al.
JOURNAL OF IMMUNOTHERAPY (2007)
Acquisition of direct antiviral effector functions by CMV-specific CD4+ T lymphocytes with cellular maturation
Joseph P. Casazza et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Activation of CDCA1-KNTC2, members of centromere protein complex, involved in pulmonary carcinogenesis
Satoshi Hayama et al.
CANCER RESEARCH (2006)
High frequency of antitumor T cells in the blood of melanoma patients before and after vaccination with tumor antigens
C Germeau et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Contrasting frequencies of antitumor and anti-vaccine T cells in metastases of a melanoma patient vaccinated with a MAGE tumor antigen
C Lurquin et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Identification of a novel human cancer/testis antigen, KM-HN-1, recognized by cellular and humoral immune responses
M Monji et al.
CLINICAL CANCER RESEARCH (2004)
Requirement for CD4 T cell help in generating functional CD8 T cell memory
DJ Shedlock et al.
SCIENCE (2003)
Determinant spreading and tumor responses after peptide-based cancer immunotherapy
A Ribas et al.
TRENDS IN IMMUNOLOGY (2003)
Allele frequencies and haplotypic associations defined by allelic DNA typing at HLA class I and class II loci in the Japanese population
S Saito et al.
TISSUE ANTIGENS (2000)
Evolution of Pacific/Asian populations inferred from HLA class II allele frequency distributions
SJ Mack et al.
TISSUE ANTIGENS (2000)
分享论文
